400-9696-311 转1
400-9696-311 转3
400-9696-311 转4
400-9696-311 转5
400客服电话
购买数据产品
400-9696-311 转1
定制咨询业务
400-9696-311 转2
数据与AI定制业务
400-9696-311 转3
商务合作及其他问题
400-9696-311 转4
投诉及建议
400-9696-311 转5
ChiCTR2500104147
正在进行
/
/
/
2025-06-11
/
/
Disabilities or Special Needs
Sports Programmes for Persons with Disabilities or Special Needs - Adapted sports programme for students with disabilities or special needs for three years
Sports Programmes for Persons with Disabilities or Special Needs - Adapted sports programme for students with disabilities or special needs for three years
The specific objectives of the project are: (1) motivate persons with DSN to get physically active at the WHO recommended level by enhancing their access to sports opportunities in school and community settings; (2) improve physical fitness and mental well-being in persons with DSN; (3) facilitate social inclusion and equity through adapted sports; and (4) advance professional competence and practice of physical education teachers and practitioners who are working with persons with DSN.
整群随机分组
其它
The random number sequence of schools and NGOs will be generated by an independent statistician using computer-based randomization software. This ensures that the randomization process is unbiased and reproducible. The allocation sequence will be securely stored and concealed from investigators and participants to maintain allocation concealment. Clusters will be randomized into either the intervention group or the waitlist control group.
Participants will be not aware of group allocation. Outcome measure assessors will be blinded to the group allocation.
The Hong Kong Jockey Club
/
200;800;860
/
2025-02-04
2027-09-30
/
Inclusion criteria are persons with clinically diagnosed DSN according to the DSM-V.;
请登录查看Exclusion criteria include medical conditions that limit participation in physical activity.;
请登录查看The Chinese University of Hong Kong
/
德琪医药2026-07-20
动脉网-最新2026-07-20
药精通Bio2026-07-20
求实药社2026-07-20
求实药社2026-07-20
康方生物Akeso2026-07-20
干细胞与外泌体2026-07-20
加科思2026-07-20
良医汇肿瘤资讯2026-07-19
GLP1减重宝典2026-07-19